These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31082785)

  • 41. Effect of dietary carbohydrates and time of year on ACTH and cortisol concentrations in adult and aged horses.
    Jacob SI; Geor RJ; Weber PSD; Harris PA; McCue ME
    Domest Anim Endocrinol; 2018 Apr; 63():15-22. PubMed ID: 29195115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy.
    Banse HE; Whitehead AE; McFarlane D; Chelikani PK
    Domest Anim Endocrinol; 2021 Jul; 76():106620. PubMed ID: 33740552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses.
    Horn R; Stewart AJ; Jackson KV; Dryburgh EL; Medina-Torres CE; Bertin FR
    J Vet Intern Med; 2021 Jan; 35(1):560-570. PubMed ID: 33368633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of pergolide in horse plasma by UPLC-MS/MS for pharmacokinetic applications.
    Jacobson GA; Pirie A; Edwards S; Hughes KJ; Rendle DI; Davies NW
    J Pharm Biomed Anal; 2014 Jun; 94():54-7. PubMed ID: 24549007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a thyrotropin-releasing hormone solution stored at room temperature for pituitary pars intermedia dysfunction testing in horses.
    Goodale L; Frank N; Hermida P; D'Oench S
    Am J Vet Res; 2015 May; 76(5):437-44. PubMed ID: 25909376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strongyle egg shedding and egg reappearance periods in horses with pituitary pars intermedia dysfunction.
    Horner A; Bamford NJ; Stear MJ; Piedrafita D; Jabbar A; Hughes KJ; El-Hage CM; Preston S
    Vet Parasitol; 2024 Jun; 328():110176. PubMed ID: 38603926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of feeding and other factors on adrenocorticotropin concentration and thyrotropin-releasing hormone stimulation test in horses and ponies.
    Drozdzewska K; Winter J; Barton AK; Merle R; Gehlen H
    Equine Vet J; 2024 Mar; 56(2):342-351. PubMed ID: 38010866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the sensitivity and specificity of basal plasma adrenocorticotrophic hormone concentration for diagnosing pituitary pars intermedia dysfunction in horses: A systematic review.
    Tatum RC; McGowan CM; Ireland JL
    Vet J; 2021 Sep; 275():105695. PubMed ID: 34099343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
    Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
    Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of withholding feed on thyrotropin-releasing hormone stimulation test results and effects of combined testing on oral sugar test and thyrotropin-releasing hormone stimulation test results in horses.
    Restifo MM; Frank N; Hermida P; Sanchez-Londoño A
    Am J Vet Res; 2016 Jul; 77(7):738-48. PubMed ID: 27347827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of delayed plasma centrifugation on equine adrenocorticotropic hormone concentration.
    Shepard KN; Haffner JC; Neal DL; Grubbs ST; Pearce GL
    J Vet Diagn Invest; 2019 Jul; 31(4):585-587. PubMed ID: 31246158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seasonal changes in plasma adrenocorticotropic hormone and α-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses.
    Funk RA; Stewart AJ; Wooldridge AA; Kwessi E; Kemppainen RJ; Behrend EN; Zhong Q; Johnson AK
    J Vet Intern Med; 2011; 25(3):579-85. PubMed ID: 21457320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.
    Hodge E; Kowalski A; Torcivia C; Lindborg S; Stefanovski D; Hart K; Frank N; van Eps A
    J Vet Intern Med; 2019 Sep; 33(5):2272-2279. PubMed ID: 31432575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses.
    Zak A; Siwinska N; Elzinga S; Barker VD; Stefaniak T; Schanbacher BJ; Place NJ; Niedzwiedz A; Adams AA
    Domest Anim Endocrinol; 2020 Jul; 72():106476. PubMed ID: 32380311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide.
    Perkins GA; Lamb S; Erb HN; Schanbacher B; Nydam DV; Divers TJ
    Equine Vet J; 2002 Nov; 34(7):679-85. PubMed ID: 12455838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of feeding status, time of the day, and season on baseline adrenocorticotropic hormone and the response to thyrotropin releasing hormone-stimulation test in healthy horses.
    Diez de Castro E; Lopez I; Cortes B; Pineda C; Garfia B; Aguilera-Tejero E
    Domest Anim Endocrinol; 2014 Jul; 48():77-83. PubMed ID: 24906932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
    Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
    Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic testing for pituitary pars intermedia dysfunction in horses.
    Dybdal NO; Hargreaves KM; Madigan JE; Gribble DH; Kennedy PC; Stabenfeldt GH
    J Am Vet Med Assoc; 1994 Feb; 204(4):627-32. PubMed ID: 8163420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction.
    Hart KA; Kitchings KM; Kimura S; Norton NA; Myrna KE
    Am J Vet Res; 2016 Nov; 77(11):1236-1244. PubMed ID: 27805438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
    Knowles EJ; Menzies-Gow NJ; Mair TS
    Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.